To elucidate the mechanisms of inhibition of CYP2A6 and CYP2B6 by (−)-POH and (−)-PAH, their metabolism-dependent inhibition potentials were investigated (Figure 2). The gene discussed is CYP2A6; the disease is pulmonary arterial hypertension.